Análise sobre a relação entre a variação na frequência do uso e drogas e saúde mental durante a pandemia por COVID-19
Data
2021-10-28
Autores
Xavier, Ana Carolina Adinolfi 
Orientadores
Galduróz, José Carlos Fernandes
Tipo
Dissertação de mestrado
Título da Revista
ISSN da Revista
Título de Volume
Resumo
Objetivo: Em dezembro do ano de 2019, uma nova doença, causada pelo coronavírus
(COVID-19 ou SARS-CoV-2), foi identificada pela primeira vez na China e,
rapidamente, se espalhou pelo mundo, causando um grande número de mortes. A
quarentena foi implementada em muitos países como medida preventiva quanto à
disseminação da doença. O impacto dessa situação no uso de drogas e na saúde
mental dos indivíduos ainda é pouco conhecido. Tomando esse contexto, este estudo
transversal procurou verificar associações entre a quarentena, o uso de substâncias
psicoativas e possíveis sintomas de depressão e ansiedade. Métodos: Os
participantes dessa pesquisa deveriam estar em processo de quarentena devido à
pandemia por COVID-19. Eles foram convidados a preencher um questionário online,
por meio de mídias sociais e Assessoria de Imprensa da UNIFESP, entre abril e maio
de 2020. Os instrumentos de avaliação utilizados foram o Patient Health
Questionnaire-9 (PHQ-9), General Anxiety Disorder-7 (GAD-7) e uma adaptação do
Alcohol, Smoking and Substance Involvement Screening Test (ASSIST). Resultados:
A amostra foi constituída por 2398 participantes, os quais atenderam aos seguintes
critérios de inclusão: estar em quarentena, ser maior de 18 anos e residir no Brasil.
Identificou-se, por meio da pesquisa, que houve uma diminuição na frequência de uso
de praticamente todas as drogas investigadas na amostra avaliada. Não houve
associação dessa redução com sintomas de ansiedade e depressão. Essa diminuição
na frequência de uso só não foi observada em indivíduos do sexo masculino, com
ocupação diferente da doméstica, e solteiros, ou seja, esses indivíduos mantiveram o
padrão de uso anterior à pandemia.
Conclusões: Este foi um estudo transversal, com dados coletados no início da
pandemia no Brasil. A menor frequência de uso de substâncias pode ser devido à
circunstância contextual de proibição de aglomeração e fechamento de locais de
consumo. É importante salientar que este estudo é um recorte, a pandemia ainda
estava em desenvolvimento no país e as consequências só poderão ser avaliadas
com estudos longitudinais.
Objective: The quarantine has been implemented in many countries since 2019, such as measure to prevent the spread of the disease caused by a coronavirus. Data about the impact of this condition on mental health and drug use was scarce on the literature. Thus, this was a cross-sectional study sought to assess possible associations between quarantine, the use of psychoactive substances and symptoms of depression and anxiety. Methods: Participants in this research should be in the quarantine process due to the COVID-19 pandemic. They were invited to complete an online questionnaire, through social media and the UNIFESP Press Office, between April and May 2020. The assessment instruments used were the General Anxiety Disorder-7 (GAD-7) scale, the Patient Health Questionnaire-9 (PHQ-9), and an adaptation of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST). Results: The sample consisted of 2398 participants who met the inclusion criteria: being in quarantine, aged 18 years or older, and residing in Brazil. It was identified, through the research, that there was a decrease in the frequency of use of practically all the drugs investigated in the evaluated sample. There was no association of this reduction with symptoms of anxiety and depression. This decrease in the frequency of use was not observed only in male individuals, with occupation other than domestic service, and single individuals, that is, these individuals maintained the pattern of use prior to the pandemic. Conclusions: This was cross-sectional research, with data collected at the beginning of the COVID-19 pandemic in Brazil. The lower frequency of substance use may be due to the contextual circumstance of banning agglomeration and closing consumption places. It is important to highlight that this is a transversal analysis, the pandemic was still developing in the country and the effects can only be evaluated with longitudinal studies.
Objective: The quarantine has been implemented in many countries since 2019, such as measure to prevent the spread of the disease caused by a coronavirus. Data about the impact of this condition on mental health and drug use was scarce on the literature. Thus, this was a cross-sectional study sought to assess possible associations between quarantine, the use of psychoactive substances and symptoms of depression and anxiety. Methods: Participants in this research should be in the quarantine process due to the COVID-19 pandemic. They were invited to complete an online questionnaire, through social media and the UNIFESP Press Office, between April and May 2020. The assessment instruments used were the General Anxiety Disorder-7 (GAD-7) scale, the Patient Health Questionnaire-9 (PHQ-9), and an adaptation of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST). Results: The sample consisted of 2398 participants who met the inclusion criteria: being in quarantine, aged 18 years or older, and residing in Brazil. It was identified, through the research, that there was a decrease in the frequency of use of practically all the drugs investigated in the evaluated sample. There was no association of this reduction with symptoms of anxiety and depression. This decrease in the frequency of use was not observed only in male individuals, with occupation other than domestic service, and single individuals, that is, these individuals maintained the pattern of use prior to the pandemic. Conclusions: This was cross-sectional research, with data collected at the beginning of the COVID-19 pandemic in Brazil. The lower frequency of substance use may be due to the contextual circumstance of banning agglomeration and closing consumption places. It is important to highlight that this is a transversal analysis, the pandemic was still developing in the country and the effects can only be evaluated with longitudinal studies.
Descrição
Citação
XAVIER, A. C. Análise sobre a relação entre a variação na frequência do uso de drogas e saúde mental durante a pandemia por COVID-19. São Paulo, 2021. 57 f. Dissertação de Mestrado (Mestrado em Psicobiologia) - Universidade Federal de São Paulo, São Paulo, 2021.